221 related articles for article (PubMed ID: 37596429)
21. Trimethylamine N-Oxide Exacerbates Neuroinflammation and Motor Dysfunction in an Acute MPTP Mice Model of Parkinson's Disease.
Quan W; Qiao CM; Niu GY; Wu J; Zhao LP; Cui C; Zhao WJ; Shen YQ
Brain Sci; 2023 May; 13(5):. PubMed ID: 37239262
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotection of Fasting Mimicking Diet on MPTP-Induced Parkinson's Disease Mice via Gut Microbiota and Metabolites.
Zhou ZL; Jia XB; Sun MF; Zhu YL; Qiao CM; Zhang BP; Zhao LP; Yang Q; Cui C; Chen X; Shen YQ
Neurotherapeutics; 2019 Jul; 16(3):741-760. PubMed ID: 30815845
[TBL] [Abstract][Full Text] [Related]
23. Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease.
Lai F; Jiang R; Xie W; Liu X; Tang Y; Xiao H; Gao J; Jia Y; Bai Q
Neurochem Res; 2018 Oct; 43(10):1986-1999. PubMed ID: 30171422
[TBL] [Abstract][Full Text] [Related]
24. TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson' disease mice.
He Y; Zhao J; Dong H; Zhang X; Duan Y; Ma Y; Yu M; Fei J; Huang F
Life Sci; 2023 Nov; 333():122171. PubMed ID: 37827233
[TBL] [Abstract][Full Text] [Related]
25. Regulation of neurotoxicity in the striatum and colon of MPTP-induced Parkinson's disease mice by gut microbiome.
Shan J; Qu Y; Wang S; Wei Y; Chang L; Ma L; Hashimoto K
Brain Res Bull; 2021 Dec; 177():103-110. PubMed ID: 34560239
[TBL] [Abstract][Full Text] [Related]
26. α-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism.
Yun SP; Kim D; Kim S; Kim S; Karuppagounder SS; Kwon SH; Lee S; Kam TI; Lee S; Ham S; Park JH; Dawson VL; Dawson TM; Lee Y; Ko HS
Mol Neurodegener; 2018 Jan; 13(1):1. PubMed ID: 29310663
[TBL] [Abstract][Full Text] [Related]
27. Berberine prevents nigrostriatal dopaminergic neuronal loss and suppresses hippocampal apoptosis in mice with Parkinson's disease.
Kim M; Cho KH; Shin MS; Lee JM; Cho HS; Kim CJ; Shin DH; Yang HJ
Int J Mol Med; 2014 Apr; 33(4):870-8. PubMed ID: 24535622
[TBL] [Abstract][Full Text] [Related]
28. Ketogenic diet protects MPTP-induced mouse model of Parkinson's disease via altering gut microbiota and metabolites.
Jiang Z; Wang X; Zhang H; Yin J; Zhao P; Yin Q; Wang Z
MedComm (2020); 2023 Jun; 4(3):e268. PubMed ID: 37200942
[TBL] [Abstract][Full Text] [Related]
29. Sodium Butyrate Exacerbates Parkinson's Disease by Aggravating Neuroinflammation and Colonic Inflammation in MPTP-Induced Mice Model.
Qiao CM; Sun MF; Jia XB; Li Y; Zhang BP; Zhao LP; Shi Y; Zhou ZL; Zhu YL; Cui C; Shen YQ
Neurochem Res; 2020 Sep; 45(9):2128-2142. PubMed ID: 32556930
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota relieves inflammation in the substantia nigra of chronic Parkinson's disease by protecting the function of dopamine neurons.
Zhang T; Wang T; Chen X; Zhao Z; Chen Z
Exp Ther Med; 2022 Jan; 23(1):52. PubMed ID: 34934429
[TBL] [Abstract][Full Text] [Related]
31. A Low-Protein, High-Carbohydrate Diet Exerts a Neuroprotective Effect on Mice with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease by Regulating the Microbiota-Metabolite-Brain Axis and Fibroblast Growth Factor 21.
Chu C; Li T; Yu L; Li Y; Li M; Guo M; Zhao J; Zhai Q; Tian F; Chen W
J Agric Food Chem; 2023 Jun; 71(23):8877-8893. PubMed ID: 37267589
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation.
Kuai XY; Yao XH; Xu LJ; Zhou YQ; Zhang LP; Liu Y; Pei SF; Zhou CL
Microb Cell Fact; 2021 May; 20(1):98. PubMed ID: 33985520
[TBL] [Abstract][Full Text] [Related]
33. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
[No Abstract] [Full Text] [Related]
34. Fecal microbiota transplantation ameliorates bone loss in mice with ovariectomy-induced osteoporosis via modulating gut microbiota and metabolic function.
Zhang YW; Cao MM; Li YJ; Lu PP; Dai GC; Zhang M; Wang H; Rui YF
J Orthop Translat; 2022 Nov; 37():46-60. PubMed ID: 36196151
[TBL] [Abstract][Full Text] [Related]
35. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model.
Dong XL; Wang X; Liu F; Liu X; Du ZR; Li RW; Xue CH; Wong KH; Wong WT; Zhao Q; Tang QJ
Int J Biol Macromol; 2020 Dec; 164():994-1005. PubMed ID: 32710966
[TBL] [Abstract][Full Text] [Related]
36. Transplantation of gut microbiota derived from Alzheimer's disease mouse model impairs memory function and neurogenesis in C57BL/6 mice.
Kim N; Jeon SH; Ju IG; Gee MS; Do J; Oh MS; Lee JK
Brain Behav Immun; 2021 Nov; 98():357-365. PubMed ID: 34500036
[TBL] [Abstract][Full Text] [Related]
37. Endurance Exercise Mediates Neuroprotection Against MPTP-mediated Parkinson's Disease via Enhanced Neurogenesis, Antioxidant Capacity, and Autophagy.
Jang Y; Kwon I; Song W; Cosio-Lima LM; Lee Y
Neuroscience; 2018 May; 379():292-301. PubMed ID: 29559387
[TBL] [Abstract][Full Text] [Related]
38. Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update.
Hediyal TA; Vichitra C; Anand N; Bhaskaran M; Essa SM; Kumar P; Qoronfleh MW; Akbar M; Kaul-Ghanekar R; Mahalakshmi AM; Yang J; Song BJ; Monaghan TM; Sakharkar MK; Chidambaram SB
Front Immunol; 2024; 15():1324018. PubMed ID: 38449863
[TBL] [Abstract][Full Text] [Related]
39. Gastrointestinal dysfunction in Parkinson's disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.
Metta V; Leta V; Mrudula KR; Prashanth LK; Goyal V; Borgohain R; Chung-Faye G; Chaudhuri KR
J Neurol; 2022 Mar; 269(3):1154-1163. PubMed ID: 33881598
[TBL] [Abstract][Full Text] [Related]
40. Safety and feasibility of faecal microbiota transplantation for patients with Parkinson's disease: a protocol for a self-controlled interventional donor-FMT pilot study.
Vendrik KE; Chernova VO; Kuijper EJ; Terveer EM; van Hilten JJ; Contarino MF;
BMJ Open; 2023 Oct; 13(10):e071766. PubMed ID: 37798034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
